Latest news
FDA to Review RSV Drug Enflonsia for Children 2 and Younger - respiratory-therapy.comrespiratory-therapy.com · Mon, 10 Aug 2026 19:09:37 GMTFDA to Review Clesrovimab for Second Season RSV Prevention - Infectious Disease AdvisorInfectious Disease Advisor · Mon, 10 Aug 2026 04:00:00 GMTFDA Reviews Clesrovimab for Second-Season RSV Prevention in High-Risk Children - Patient Care OnlinePatient Care Online · Sat, 08 Aug 2026 02:54:59 GMT